Advertisement

Topics

Novartis Pharmaceuticals Corp Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

22:39 EDT 7 Aug 2018 | BioPortfolio Reports

Novartis Pharmaceuticals Corp Mergers Acquisitions MA, Partnerships Alliances and Investment Report


Summary


Marketline's Novartis Pharmaceuticals Corp Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Novartis Pharmaceuticals Corp since January2007.


Synopsis


Marketline's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.


Key Hightlights


This report includes Novartis Pharmaceuticals Corp's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all MA, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Novartis Pharmaceuticals Corp. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.


Scope


Provides intelligence on Novartis Pharmaceuticals Corp's MA, strategic partnerships and alliances, capital raising and private equity transactions.

Detailed reports of various financial transactions undertaken by Novartis Pharmaceuticals Corp and its subsidiaries since 2007.

Information about key financial and legal advisors for Novartis Pharmaceuticals Corp's financial deals transactions.

Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity.


Reasons to buy


Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances.

Form an independent opinion about Novartis Pharmaceuticals Corp's growth strategies through the organic and inorganic activities undertaken since 2007.

Track your competitors' business structure and growth strategies.

Original Article: Novartis Pharmaceuticals Corp Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

NEXT ARTICLE

More From BioPortfolio on "Novartis Pharmaceuticals Corp Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...